What do you do if you’re a medical technology startup while waiting for the FDA to approve your flagship iPhone-based product?
If you’re AliveCor, you launch a veterinary version of it.
The product in question is AliveCor’s iPhone ECG heart monitor, which the company showed off nearly two years ago, at the CES in 2011. The device allows a medical professional to assess a patient’s heart rhythm, providing more data than a stethoscope or manual check of their pulse. Although the device has broad potential, it has yet to be approved by the FDA..